Revolution Medicines Chief Development Officer Alan B. Sandler disposes of $1,264,082 in common shares

RVMD•2026-10-01

Revolution Medicines Chief Development Officer Alan B. Sandler exercised options for 6,000 shares at $58.84 and sold 6,309 shares on Sept. 29, 2026, at weighted-average prices of $200.8188 to $204.7224. He directly held 52,559 shares afterward.

1. Share transactions

Sandler exercised stock options for 6,000 Revolution Medicines shares at $58.84 on Sept. 29, 2026, and sold 6,309 shares that day at weighted-average prices ranging from $200.8188 to $204.7224. His direct holdings ended at 52,559 common shares.

Sources

Revolution Medicines Chief Development Officer Alan B. Sandler disposes of $1,264,082 in common shares

Sec

Revolution Medicines Chief Development Officer Alan B. Sandler disposes of $1,264,082 in common shares

1. Share transactions

Related News

HPE EVP Rami Rahim disposes of 34,456 shares worth $2,116,683.52

PodcastOne director D. Jonathan Merriman reports purchase of 7,000 shares valued at $15,470

Chronoscale announces agreements bringing contracted run-rate revenue to $1 billion and sale of Ekso Bionics business unit

Sources

Revolution Medicines Chief Development Officer Alan B. Sandler disposes of $1,264,082 in common shares

PBF Energy unit enters amended revolving credit agreement

Mohawk Industries schedules third-quarter earnings conference call